Lithium (low-dose)

lithium orotate · low-dose lithium · microdose lithium

Trace/low-dose lithium promoted for mood, brain aging and longevity.

TypePrescription drug (at clinical doses)

⚠ Prescription drug — use only under medical supervision

The grade answers: What does the human evidence support for: Mood & putative neuroprotection?

Grade

Weak

The grade rates evidence quality — it is not advice to take or buy.

Class: Trace element / drug
Primary use: Mood & putative neuroprotection
Evidence strength: low
Last reviewed: 2026-07-01

Bottom line

Interesting population signals and a real psychiatric drug at higher doses — but a narrow safety margin and almost no controlled 'microdose' evidence make casual self-supplementation a genuinely bad idea. This is a caution, not a recommendation.

What the evidence says

The longevity interest comes from ecological studies suggesting regions with more lithium in drinking water have lower suicide and, in some analyses, dementia rates, plus lithium's established (high-dose) use in bipolar disorder and preclinical neuroprotection signals. But the leap to 'microdose lithium orotate supplements extend healthspan' is not supported by controlled human trials, supplement products are unregulated in dose and purity, and lithium has a famously narrow therapeutic window — the gap between a therapeutic and a toxic level is small. Grade D reflects weak human evidence for the supplement claim combined with real toxicity potential. We include it mainly to warn, not to endorse.

Key studies

[1]
Lithium in drinking water and suicide/dementia (ecological studies) · observational
Population associations only — cannot establish a supplement benefit.
Open on PubMed ↗
[2]
Low-dose lithium and cognition/neuroprotection · review
Hypothesis-generating; controlled human evidence is thin.
Open on PubMed ↗
[3]
Lithium toxicity and monitoring · review
Narrow safety window; requires medical monitoring.
Open on PubMed ↗

See all studies on PubMed ↗

Mechanism

Proposed inhibition of GSK-3β and effects on autophagy and neurotrophic signalling underlie the neuroprotection hypothesis; at clinical doses it is a mood stabiliser by incompletely understood mechanisms.

Safety

This is the key point. Lithium has a narrow therapeutic index; even outside clearly toxic ranges it can affect the thyroid and kidneys with chronic use, and it interacts with common drugs (NSAIDs, diuretics, ACE inhibitors) that can raise blood levels dangerously. 'Low-dose' supplements are not quality-controlled. Do not self-experiment: any lithium use belongs under medical supervision with blood monitoring.

Dosage context

Clinical psychiatric dosing is individualised and monitored with blood tests. 'Microdose' supplement products (e.g. lithium orotate) provide much smaller amounts, but without trials establishing benefit or a safe long-term dose — so no responsible dose can be stated here.

Examples of application

Not self-dosed: any lithium use belongs under medical supervision with blood tests.
Population signals are interesting but not a basis for supplements.
Included here to caution, not to recommend.

From the field

This is the entry where our job is to slow you down, not sell you. The population data are genuinely intriguing, but lithium is a real drug with a narrow safety margin and no controlled evidence for the supplement version. Grade D — and please don't microdose lithium on your own.

How we assign grades → Method